Jaci Hermstad (Photo courtesy of Lori Hermstad)
How a tailored ALS drug could help broaden rare disease therapies
In 2020, Jaci Hermstad died at age 26 from a rare and aggressive form of ALS. But her story didn’t end there.
A drug that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
